Prevalence of Comorbidity between Dry Eye and Allergic Conjunctivitis: A Systematic Review and Meta-Analysis.
allergic conjunctivitis
comorbidity rate
complementary treatment
dry eye
meta-analysis
perennial allergic conjunctivitis
seasonal allergic conjunctivitis
systematic review
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
23 Jun 2022
23 Jun 2022
Historique:
received:
07
05
2022
revised:
16
06
2022
accepted:
21
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
This systematic review aimed to determine the comorbid dry eye (DE) and allergic conjunctivitis (AC) prevalence. We searched PubMed and EMBASE for articles published until 22 March 2022, combining the terms "(dry eye OR keratoconjunctivitis sicca) AND allergic conjunctivitis." Study-specific estimates (DE and AC incidence rates among patients with AC and DE, respectively) were combined using the one-group meta-analysis in a random-effects model. The initial search yielded 700 studies. Five articles reporting AC incidence among individuals with DE and six articles reporting DE incidence among individuals with AC were included in the qualitative synthesis. In these nine articles, the total sample size was 7254 patients. The DE incidence among individuals with AC was 0.9-97.5%; the AC incidence among individuals with DE was 6.2-38.0%. One-group meta-analysis using a random-effects model showed that 47.2% (95% confidence interval: 0.165-0.779; 320/1932 cases) of patients with AC had comorbid DE and 17.8% (95% confidence interval: 0.120-0.236; 793/4855 cases) of patients with DE had comorbid AC, as defined by each article. Complimentary screening and treatment for patients with DE and AC may improve long-term outcomes and prevent chronic ocular damage in highly susceptible populations.
Identifiants
pubmed: 35806928
pii: jcm11133643
doi: 10.3390/jcm11133643
pmc: PMC9267454
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Japan Agency for Medical Research and Development
ID : JP21ek0410063
Organisme : Japan Society for the Promotion of Science
ID : 20KK0207
Organisme : Japan Society for the Promotion of Science
ID : 20K23168
Organisme : Japan Society for the Promotion of Science
ID : 21K17311
Organisme : Japan Society for the Promotion of Science
ID : 21K20998
Organisme : Japan Society for the Promotion of Science
ID : 22K16983
Organisme : The Institute for Environmental & Gender-specific Medicine, Juntendo University
ID : Medical Research Encouragement Prize 2018
Organisme : The Institute for Environmental & Gender-specific Medicine, Juntendo University
ID : Medical Research Encouragement Prize 2021
Organisme : Kondou Kinen Medical Foundation
ID : Medical Research Encouragement Prize 2020
Organisme : The Cell Science Research Foundation
ID : Medical Research Encouragement Prize 2022
Organisme : The OTC Self-Medication Promotion Foundation
ID : Medical Research Encouragement Prize 2021
Références
Ann Allergy Asthma Immunol. 2012 Mar;108(3):163-6
pubmed: 22374198
Curr Opin Allergy Clin Immunol. 2015 Oct;15(5):482-8
pubmed: 26258920
BMC Ophthalmol. 2015 Dec 17;15 Suppl 1:154
pubmed: 26818460
Adv Ther. 2014 Nov;31(11):1169-81
pubmed: 25376447
Allergy Asthma Clin Immunol. 2020 Jan 21;16:5
pubmed: 31993069
Recent Pat Inflamm Allergy Drug Discov. 2014;8(2):139-53
pubmed: 25000933
Allergy. 2021 Dec;76(12):3820-3824
pubmed: 34480802
Middle East Afr J Ophthalmol. 2015 Oct-Dec;22(4):467-71
pubmed: 26692719
Cornea. 2006 Apr;25(3):277-80
pubmed: 16633026
Adv Ther. 2020 Jan;37(1):316-328
pubmed: 31728824
Adv Ther. 2020 Feb;37(2):707-717
pubmed: 31834617
Recent Pat Inflamm Allergy Drug Discov. 2009 Jun;3(2):118-27
pubmed: 19519588
Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2483-9
pubmed: 11581187
Am J Ophthalmol. 2013 Oct;156(4):759-66
pubmed: 23891330
J Med Internet Res. 2020 Jun 26;22(6):e18996
pubmed: 32589162
Ophthalmology. 2019 May;126(5):766-768
pubmed: 30550734
NPJ Digit Med. 2021 Dec 20;4(1):171
pubmed: 34931013
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Cutan Ocul Toxicol. 2016 Mar;35(1):49-52
pubmed: 25694171
Ophthalmology. 1995 Feb;102(2):302-9
pubmed: 7862418
Acta Ophthalmol. 2009 Aug;87(5):549-54
pubmed: 18631332
Allergol Int. 2022 Jul;71(3):325-334
pubmed: 35105520
Expert Opin Pharmacother. 2013 Aug;14(11):1449-65
pubmed: 23822862
Eye Contact Lens. 2006 Dec;32(6):272-6
pubmed: 17099387
Ocul Surf. 2017 Jul;15(3):334-365
pubmed: 28736337
Heart Lung Circ. 2020 May;29(5):729-741
pubmed: 31133516
Cornea. 2020 Nov;39 Suppl 1:S39-S46
pubmed: 33055549
Am J Ophthalmol. 2017 Aug;180:72-85
pubmed: 28579061
Ital J Pediatr. 2013 Mar 14;39:18
pubmed: 23497516
Ocul Surf. 2022 Apr 25;25:19-25
pubmed: 35483601
J Clin Med. 2022 May 24;11(11):
pubmed: 35683352
Cont Lens Anterior Eye. 2012 Oct;35(5):240-2
pubmed: 22580008
Ocul Immunol Inflamm. 2021 Aug 18;29(6):1168-1176
pubmed: 33544639
Ocul Surf. 2020 Apr;18(2):312-319
pubmed: 32113987
Clin Ophthalmol. 2017 Sep 30;11:1769-1775
pubmed: 29033539
Niger Med J. 2014 Mar;55(2):166-70
pubmed: 24791053
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Int J Immunopathol Pharmacol. 1999 Jan-Apr;12(3):133-137
pubmed: 12783641
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES192-DES199
pubmed: 30481826
Clin Exp Allergy. 2006 Jun;36(6):777-84
pubmed: 16776679
Adv Ther. 2017 Mar;34(3):732-743
pubmed: 28181147
Sci Rep. 2018 Jan 30;8(1):1918
pubmed: 29382858
J Am Coll Cardiol. 2020 Jan 28;75(3):273-285
pubmed: 31976865
Mol Vis. 2010 Oct 14;16:2084-91
pubmed: 21042565
Home Healthc Now. 2018 Mar/Apr;36(2):74-83
pubmed: 29498987
Allergol Int. 2020 Oct;69(4):510-518
pubmed: 32651122
JAMA Ophthalmol. 2020 Jan 1;138(1):58-68
pubmed: 31774457
Jpn J Ophthalmol. 2021 Mar;65(2):271-281
pubmed: 33411099
Acta Ophthalmol. 2016 Dec;94(8):e727-e730
pubmed: 27226346
Asian Pac J Allergy Immunol. 2001 Dec;19(4):237-44
pubmed: 12009073